Tiziana Appoints COO
This article was originally published in Scrip
Tiziana Life Sciences Plc. has appointed James F. Tripp chief operating officer and head of global clinical operations. Tripp brings 20 years' of experience to the company and most recently was director, clinical management at Novo Nordisk, A/S. Prior to this, he was therapeutic area project manager for inflammation programs at Regeneron Pharmaceuticals.
Register for our free email digests: